Skip to content

Multipharma

Active
Cooperative companyfounded 200422 yrs activeMarie Curiesquare 30, 1070 Anderlecht, BelgiumKBO/BCE: BE 0866.855.346
Summary

Multipharma has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €128.1m and a net result of -€2.9m. Equity is growing by ~4.3% per year across the filed fiscal years. Its solvency ranks better than 61% of 4911 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisWatch ReportCompare
MultipharmaActiveChecked score 89/100
Risk analysis ReportCompare

Directors

Directors
no sitting director read yet, last change in 2026
No directors read yet: 2 of 114 Gazette acts processed. See the function holders in the CBE →

Mandate history

1 person since 2026, 0 in office
Show
  • Day-to-day management
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Delphine HAHAJI
  • Member of the executive committee, until 30-04-2026
  • Member of the executive committee, until 30-04-2026
See the board, name and seat on a given date →

Owners and capital

Owners

1 owner

Chain of control

  1. MULTIPHARMA GROUP 100%
  2. Multipharma

Highest known parent: MULTIPHARMA GROUP. The sources do not say who stands above it.

Owners 1

According to the 2025 annual accounts of Multipharma and those of the other companies, the acts in the Belgian Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Companies Code and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

We would like to set cookies. That happens only with your consent. What we measure